These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2617230)
41. Vitamin E changes the membrane fluidity of human platelets. Steiner M Biochim Biophys Acta; 1981 Jan; 640(1):100-5. PubMed ID: 7213680 [TBL] [Abstract][Full Text] [Related]
42. Effects of aurothioglucose and auranofin on radiographic progression in rheumatoid arthritis. Van Riel PL; Larsen A; Van de Putte LB; Gribnau FW Clin Rheumatol; 1986 Sep; 5(3):359-64. PubMed ID: 3096626 [TBL] [Abstract][Full Text] [Related]
43. Monosodium urate monohydrate crystal induced changes in membrane fluidity: a fluorescence polarization study. Burt HM; Jackson JK J Rheumatol; 1988 Jul; 15(7):1144-51. PubMed ID: 3172115 [TBL] [Abstract][Full Text] [Related]
44. Auranofin versus placebo in the treatment of rheumatoid arthritis. Wenger ME; Alexander S; Bland JH; Blechman WJ Am J Med; 1983 Dec; 75(6A):123-7. PubMed ID: 6419593 [TBL] [Abstract][Full Text] [Related]
45. The interaction of auranofin and buthionine sulfoximine blocks activation of human peripheral T lymphocytes. Vint IA; Chain BM; Foreman JC Cell Immunol; 1993 Nov; 152(1):152-61. PubMed ID: 8242758 [TBL] [Abstract][Full Text] [Related]
46. Significance of altered fluidity of plasma membranes of the liver and kidney in rats with sepsis. Yoshida M; Tanaka J; Tamura J; Fujita K; Kasamatsu T; Kohmoto M; Kaido T J Surg Res; 1995 Feb; 58(2):131-6. PubMed ID: 7861763 [TBL] [Abstract][Full Text] [Related]
47. A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis. Jessop JD; O'Sullivan MM; Lewis PA; Williams LA; Camilleri JP; Plant MJ; Coles EC Br J Rheumatol; 1998 Sep; 37(9):992-1002. PubMed ID: 9783766 [TBL] [Abstract][Full Text] [Related]
48. The effect of simvastatin on erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary bypass: a randomized controlled study. Coccia R; Spadaccio C; Foppoli C; Perluigi M; Covino E; Lusini M; Chello M Clin Ther; 2007 Aug; 29(8):1706-17. PubMed ID: 17919551 [TBL] [Abstract][Full Text] [Related]
49. Effect of auranofin on DNA and protein synthesis in human lymphocytes. Finkelstein AE; Burrone OR; Walz DT; Misher A J Rheumatol; 1977; 4(3):245-51. PubMed ID: 336886 [TBL] [Abstract][Full Text] [Related]
50. Fluorescence polarization study on the increase of membrane fluidity of human erythrocyte ghosts induced by synthetic water-soluble polymers. Ohno H; Shimidzu N; Tsuchida E; Sasakawa S; Honda K Biochim Biophys Acta; 1981 Dec; 649(2):221-8. PubMed ID: 7317393 [TBL] [Abstract][Full Text] [Related]
51. Developmental changes in synaptic membrane fluidity: a comparison of 1,6-diphenyl-1,3,5-hexatriene (DPH) and 1-[4-(trimethylamino)phenyl]-6-phenyl-1,3,5-hexatriene (TMA-DPH). Hitzemann RJ; Harris RA Brain Res; 1984 May; 316(1):113-20. PubMed ID: 6733531 [TBL] [Abstract][Full Text] [Related]
52. Serum gold concentrations during treatment with auranofin. Van Riel PL; Gribnau FW; Van de Putte LB; Arts CW; Van Aernsbergen A Clin Rheumatol; 1987 Mar; 6(1):50-4. PubMed ID: 3581698 [TBL] [Abstract][Full Text] [Related]
53. Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study. Rao UR; Naidu MU; Kumar TR; Shobha U; Askar MA; Ahmed N; Sarada P; Venubabu K; Shantaram V; Menon GN J Rheumatol; 1995 Jul; 22(7):1235-40. PubMed ID: 7562751 [TBL] [Abstract][Full Text] [Related]
54. [Long-term therapy with gold salts in rheumatoid arthritis. Review of the literature and personal contribution]. Copertari N; Cordioli E; Martinelli M Minerva Med; 1993 May; 84(5):219-25. PubMed ID: 8316339 [TBL] [Abstract][Full Text] [Related]
55. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial. Bombardier C; Ware J; Russell IJ; Larson M; Chalmers A; Read JL Am J Med; 1986 Oct; 81(4):565-78. PubMed ID: 3532786 [TBL] [Abstract][Full Text] [Related]
56. Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: correlation with clinical and immunological parameters and with the response to auranofin treatment. Boiardi L; Macchioni P; Salvarani C; Rossi F; Casadei-Maldini M; Mancini R; Beltrandi E; Portioli I Clin Exp Rheumatol; 1994; 12(4):357-62. PubMed ID: 7955597 [TBL] [Abstract][Full Text] [Related]
57. Auranofin is safe and superior to placebo in elderly-onset rheumatoid arthritis. Glennås A; Kvien TK; Andrup O; Clarke-Jenssen O; Karstensen B; Brodin U Br J Rheumatol; 1997 Aug; 36(8):870-7. PubMed ID: 9291856 [TBL] [Abstract][Full Text] [Related]
58. [Well controlled comparative study in early rheumatoid arthritis with gold sodium thiomalate vs. auranofin]. Yamamoto S; Mitomo N; Saito T; Nishioka K; Inoue K; Uchida S; Ohata N; Murasawa A; Suzuki A; Mitsui T Ryumachi; 1990 Feb; 30(1):26-44. PubMed ID: 2116042 [TBL] [Abstract][Full Text] [Related]
59. Single dose pharmacokinetics of auranofin in rheumatoid arthritis. Blocka K; Furst DE; Landaw E; Dromgoole S; Blomberg A; Paulus HE J Rheumatol Suppl; 1982; 8():110-9. PubMed ID: 6813473 [TBL] [Abstract][Full Text] [Related]
60. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Ward JR; Williams HJ; Egger MJ; Reading JC; Boyce E; Altz-Smith M; Samuelson CO; Willkens RF; Solsky MA; Hayes SP Arthritis Rheum; 1983 Nov; 26(11):1303-15. PubMed ID: 6416259 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]